TAXATION
Mutual Fund Distributions: How Capital Gain Distributions Are Taxed
For mutual fund investors, taxes are inevitable. Even if you’re a long-term buy...
Fidelity® Select Biotechnology
- FBIOX
- Price as of: Oct 23, 2020
-
$24.41
N/A N/A
- Primary Theme
- Health Care Sector Equity
- Fund Company
- Fidelity Investments
- Share Class
FBIOX - Snapshot
Vitals
- YTD Return 11.2%
- 3 Yr Annualized Return 10.1%
- 5 Yr Annualized Return 8.9%
- Net Assets $7.44 B
- Holdings in Top 10 35.2%
52 WEEK LOW AND HIGH
$24.41
$16.18
$25.74
Expenses
OPERATING RELATED FEES
- Expense Ratio 0.72%
SALES FEES
- Front Load N/A
- Deferred Load N/A
BROKERAGE FEES
- Turnover 50.00%
TRADING FEES
- Max Redemption Fee N/A
Min Investment
- Standard (Taxable) $0
- IRA $2,500
Fund Classification
-
Primary Theme
Health Care Sector Equity
- Fund Type Open End Mutual Fund
- Investment Style Health
FBIOX - Profile
Distributions
- YTD Total Return 11.2%
- 3 Yr Annualized Total Return 10.1%
- 5 Yr Annualized Total Return 8.9%
- Capital Gain Distribution Frequency Semi-Annually
- Net Income Ratio 0.22%
- Dividend Yield 0.0%
- Dividend Distribution Frequency Annually
Fund Details
-
Legal NameFidelity® Select Biotechnology Portfolio
-
Fund Family NameFidelity Investments
-
Inception DateDec 16, 1985
-
Shares OutstandingN/A
-
Share ClassNo Load
-
CurrencyUSD
-
Domiciled CountryUnited States
-
ManagerRajiv Kaul
Fund Description
The fund invests primarily in common stocks. It normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.
FBIOX - Performance
Return Ranking - Trailing
| Period | FBIOX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 11.2% | -7.5% | 109.2% | 55.56% |
| 1 Yr | 45.5% | 8.3% | 128.7% | 13.04% |
| 3 Yr | 10.1%* | 0.1% | 38.7% | 67.13% |
| 5 Yr | 8.9%* | 0.4% | 30.0% | 65.47% |
| 10 Yr | 19.6%* | 8.9% | 20.1% | 4.07% |
* Annualized
Return Ranking - Calendar
| Period | FBIOX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2019 | 24.5% | 3.8% | 63.8% | 26.21% |
| 2018 | -19.1% | -49.7% | 21.5% | 92.70% |
| 2017 | 26.1% | -59.8% | 54.4% | 17.78% |
| 2016 | -26.2% | -36.6% | 11.6% | 95.35% |
| 2015 | 6.6% | -62.4% | 27.9% | 13.93% |
Total Return Ranking - Trailing
| Period | FBIOX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 11.2% | -7.5% | 109.2% | 55.56% |
| 1 Yr | 45.5% | 2.7% | 128.7% | 12.42% |
| 3 Yr | 10.1%* | 0.1% | 38.7% | 62.94% |
| 5 Yr | 8.9%* | 0.4% | 30.0% | 62.59% |
| 10 Yr | 19.6%* | 8.9% | 20.1% | 4.07% |
* Annualized
Total Return Ranking - Calendar
| Period | FBIOX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2019 | 24.5% | 3.8% | 63.8% | 26.21% |
| 2018 | -15.8% | -25.3% | 22.2% | 88.32% |
| 2017 | 27.9% | -10.8% | 54.4% | 16.30% |
| 2016 | -23.8% | -36.6% | 11.6% | 93.02% |
| 2015 | 13.9% | -16.6% | 27.9% | 6.56% |
NAV & Total Return History
FBIOX - Holdings
Concentration Analysis
| FBIOX | Category Low | Category High | FBIOX % Rank | |
|---|---|---|---|---|
| Net Assets | 7.44 B | 2.6 M | 48.7 B | 9.83% |
| Number of Holdings | 287 | 26 | 431 | 2.89% |
| Net Assets in Top 10 | 2.63 B | 670 K | 18.8 B | 13.29% |
| Weighting of Top 10 | 35.19% | 13.2% | 76.3% | 69.94% |
Top 10 Holdings
- AbbVie Inc 8.40%
- AbbVie Inc 8.40%
- AbbVie Inc 8.40%
- AbbVie Inc 8.40%
- AbbVie Inc 8.40%
- AbbVie Inc 8.40%
- AbbVie Inc 8.40%
- AbbVie Inc 8.40%
- AbbVie Inc 8.40%
- AbbVie Inc 8.40%
Asset Allocation
| Weighting | Return Low | Return High | FBIOX % Rank | |
|---|---|---|---|---|
| Stocks | 96.63% | 61.47% | 100.59% | 72.83% |
| Other | 2.31% | -3.06% | 6.07% | 6.36% |
| Cash | 1.05% | -0.68% | 32.46% | 48.55% |
| Preferred Stocks | 0.00% | 0.00% | 6.63% | 56.07% |
| Convertible Bonds | 0.00% | 0.00% | 0.03% | 47.98% |
| Bonds | 0.00% | 0.00% | 16.11% | 49.71% |
Stock Sector Breakdown
| Weighting | Return Low | Return High | FBIOX % Rank | |
|---|---|---|---|---|
| Healthcare | 100.00% | 61.81% | 100.00% | 19.08% |
| Utilities | 0.00% | 0.00% | 0.00% | 46.82% |
| Technology | 0.00% | 0.00% | 20.28% | 56.07% |
| Real Estate | 0.00% | 0.00% | 6.03% | 51.45% |
| Industrials | 0.00% | 0.00% | 6.39% | 50.87% |
| Financial Services | 0.00% | 0.00% | 2.72% | 68.21% |
| Energy | 0.00% | 0.00% | 0.00% | 46.82% |
| Communication Services | 0.00% | 0.00% | 3.21% | 49.13% |
| Consumer Defense | 0.00% | 0.00% | 34.31% | 52.02% |
| Consumer Cyclical | 0.00% | 0.00% | 1.21% | 52.60% |
| Basic Materials | 0.00% | 0.00% | 2.61% | 63.01% |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | FBIOX % Rank | |
|---|---|---|---|---|
| US | 87.19% | 47.91% | 100.00% | 28.90% |
| Non US | 9.44% | 0.00% | 43.87% | 75.14% |
FBIOX - Expenses
Operational Fees
| FBIOX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 0.72% | 0.08% | 25.14% | 75.90% |
| Management Fee | 0.54% | 0.00% | 1.25% | 31.21% |
| 12b-1 Fee | N/A | 0.00% | 1.00% | N/A |
| Administrative Fee | N/A | 0.03% | 0.40% | N/A |
Sales Fees
| FBIOX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | N/A | 3.50% | 5.75% | N/A |
| Deferred Load | N/A | 1.00% | 5.00% | N/A |
Trading Fees
| FBIOX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | 1.00% | 2.00% | 95.12% |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| FBIOX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | 50.00% | 0.70% | 252.00% | 70.12% |
FBIOX - Distributions
Dividend Yield Analysis
| FBIOX | Category Low | Category High | FBIOX % Rank | |
|---|---|---|---|---|
| Dividend Yield | 0.00% | 0.00% | 3.15% | 56.65% |
Dividend Distribution Analysis
| FBIOX | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | Annually | Annually | Quarterly | Annually |
Net Income Ratio Analysis
| FBIOX | Category Low | Category High | FBIOX % Rank | |
|---|---|---|---|---|
| Net Income Ratio | 0.22% | -2.53% | 2.53% | 34.73% |
Capital Gain Distribution Analysis
| FBIOX | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency | Semi-Annually | Annually | Semi-Annually | Annually |
FBIOX - Fund Manager Analysis
Managers
Rajiv Kaul
Start Date
Tenure
Tenure Rank
Oct 12, 2005
14.98
15.0%
Kaul is a portfolio manager with Fidelity Investments. Since joining Fidelity Investments in 1996, he has worked as a research analyst and portfolio manager. Kaul also manages another Fidelity fund. Prior to Fidelity, Kaul worked at Mckinsey & Company. He is the recipient of the Kann Rasmusson Environment Award, the Dean's Summer Research Award and a Ford Undergraduate Fellowship.
Tenure Analysis
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 0.08 | 23.06 | 7.22 | 20.43 |
